Login / Signup

Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study.

Gilad RabinaDana BarequetMichael MimouniShimon KurtzGabi ShemeshAmir RosenblattEldar Rosenfeld
Published in: European journal of ophthalmology (2019)
Intracameral bevacizumab during mitomycin C trabeculectomy in patients with primary open-angle glaucoma apparently does not improve success rates. The adjuvant use of intracameral bevacizumab is therefore not justified.
Keyphrases
  • metastatic colorectal cancer
  • cataract surgery
  • double blind
  • open label
  • early stage
  • placebo controlled
  • phase iii
  • phase ii
  • study protocol